152 related articles for article (PubMed ID: 19352727)
1. Adverse effects of posterior lumbar interbody fusion using rhBMP-2.
Smoljanovic T; Bojanic I; Delimar D
Eur Spine J; 2009 Jun; 18(6):920-3; author reply 924. PubMed ID: 19352727
[No Abstract] [Full Text] [Related]
2. Safety of posterior interbody fusions of the lumbar spine using rhBMP-2.
Smoljanovic T; Bojanic I; Vlahovic Z
J Spinal Disord Tech; 2010 Feb; 23(1):78. PubMed ID: 20134288
[No Abstract] [Full Text] [Related]
3. Posterior lumbar interbody fusion using rhBMP-2.
Meisel HJ; Schnöring M; Hohaus C; Minkus Y; Beier A; Ganey T; Mansmann U
Eur Spine J; 2008 Dec; 17(12):1735-44. PubMed ID: 18839225
[TBL] [Abstract][Full Text] [Related]
4. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages.
Haid RW; Branch CL; Alexander JT; Burkus JK
Spine J; 2004; 4(5):527-38; discussion 538-9. PubMed ID: 15363423
[TBL] [Abstract][Full Text] [Related]
5. Re: Mindea SA, Shih P, Song JK. Recombinant human bone morphogenetic protein-2-induced radiculitis in elective minimally invasive transforaminal lumbar interbody fusions: a series review. Spine 2009;34:1480-5.
Smoljanovic T; Bojanic I; Dokuzovic S
Spine (Phila Pa 1976); 2010 Apr; 35(8):929. PubMed ID: 20395781
[No Abstract] [Full Text] [Related]
6. Bone morphogenetic protein-2-mediated pain and inflammation in a rat model of posterolateral arthrodesis.
Mitchell K; Shah JP; Dalgard CL; Tsytsikova LV; Tipton AC; Dmitriev AE; Symes AJ
BMC Neurosci; 2016 Dec; 17(1):80. PubMed ID: 27905881
[TBL] [Abstract][Full Text] [Related]
7. Retrograde ejaculation following single-level anterior lumbar surgery with or without recombinant human bone morphogenetic protein-2 in 5 randomized controlled trials: clinical article.
Burkus JK; Dryer RF; Peloza JH
J Neurosurg Spine; 2013 Feb; 18(2):112-21. PubMed ID: 23199378
[TBL] [Abstract][Full Text] [Related]
8. Vertebral osteolysis originating from subchondral cyst end plate defects in transforaminal lumbar interbody fusion using rhBMP-2. Report of two cases.
Balseiro S; Nottmeier EW
Spine J; 2010 Jul; 10(7):e6-e10. PubMed ID: 20488766
[TBL] [Abstract][Full Text] [Related]
9. Symptomatic ectopic bone formation after off-label use of recombinant human bone morphogenetic protein-2 in transforaminal lumbar interbody fusion.
Chen NF; Smith ZA; Stiner E; Armin S; Sheikh H; Khoo LT
J Neurosurg Spine; 2010 Jan; 12(1):40-6. PubMed ID: 20043763
[TBL] [Abstract][Full Text] [Related]
10. A comparison of radiographic and clinical outcomes of anterior lumbar interbody fusion performed with either a cellular bone allograft containing multipotent adult progenitor cells or recombinant human bone morphogenetic protein-2.
Lee DD; Kim JY
J Orthop Surg Res; 2017 Aug; 12(1):126. PubMed ID: 28841904
[TBL] [Abstract][Full Text] [Related]
11. Vertebral bone resorption after transforaminal lumbar interbody fusion with bone morphogenetic protein (rhBMP-2).
McClellan JW; Mulconrey DS; Forbes RJ; Fullmer N
J Spinal Disord Tech; 2006 Oct; 19(7):483-6. PubMed ID: 17021411
[TBL] [Abstract][Full Text] [Related]
12. Symptomatic ectopic intracanal ossification after transforaminal lumbar interbody fusion with rhBMP-2.
Lehman RA; Kang DG
Spine J; 2012 Jun; 12(6):530-1. PubMed ID: 22682741
[No Abstract] [Full Text] [Related]
13. Effectiveness and safety of recombinant human bone morphogenetic protein-2 versus local bone graft in primary lumbar interbody fusions.
Adams CL; Ogden K; Robertson IK; Broadhurst S; Edis D
Spine (Phila Pa 1976); 2014 Jan; 39(2):164-71. PubMed ID: 24153173
[TBL] [Abstract][Full Text] [Related]
14. Revision surgery after interbody fusion with rhBMP-2: a cautionary tale for spine surgeons.
Rodgers SD; Marascalchi BJ; Grobelny BT; Smith ML; Samadani U
J Neurosurg Spine; 2013 Jun; 18(6):582-7. PubMed ID: 23560709
[TBL] [Abstract][Full Text] [Related]
15. Nerve injury and recovery after lateral lumbar interbody fusion with and without bone morphogenetic protein-2 augmentation: a cohort-controlled study.
Lykissas MG; Aichmair A; Sama AA; Hughes AP; Lebl DR; Cammisa FP; Girardi FP
Spine J; 2014 Feb; 14(2):217-24. PubMed ID: 24269858
[TBL] [Abstract][Full Text] [Related]
16. The effect of recombinant human bone morphogenetic protein-2 in single-level posterior lumbar interbody arthrodesis.
Michielsen J; Sys J; Rigaux A; Bertrand C
J Bone Joint Surg Am; 2013 May; 95(10):873-80. PubMed ID: 23677353
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous posterior-lateral lumbar interbody fusion for degenerative disc disease using a B-Twin expandable spinal spacer.
Xiao L; Xiong D; Zhang Q; Jian J; Zheng H; Luo Y; Dai J; Zhang D
Eur Spine J; 2010 Feb; 19(2):325-30. PubMed ID: 19784677
[TBL] [Abstract][Full Text] [Related]
18. Minimal invasive anterior lumbar interbody fusion (mini ALIF).
Aebi M; Parthasarathy S; Avadhani A; Rajasekaran S
Eur Spine J; 2010 Feb; 19(2):335-6. PubMed ID: 20140463
[No Abstract] [Full Text] [Related]
19. Safety of transforaminal lumbar interbody fusion and intervertebral recombinant human bone morphogenetic protein-2.
Villavicencio AT; Burneikiene S; Nelson EL; Bulsara KR; Favors M; Thramann J
J Neurosurg Spine; 2005 Dec; 3(6):436-43. PubMed ID: 16381205
[TBL] [Abstract][Full Text] [Related]
20. Anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2: a prospective study of complications.
Malham GM; Parker RM; Ellis NJ; Blecher CM; Chow FY; Claydon MH
J Neurosurg Spine; 2014 Dec; 21(6):851-60. PubMed ID: 25279655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
